Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Olympia
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Olympia, WA

Studies commonly pay $75 to $4,500 per completed study

234 clinical trials are currently recruiting participants within 30 miles of Olympia. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

234studies recruiting
5+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Olympia right now

Top 25 of 234 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Colitis Ulcerative Phase 2 Interventional 204 participants sought
Washington Gastroenterology - Tacoma- Site Number : 8400009 — Tacoma, Washington (25.8 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06867094)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Northwest Medical Specialties, PLLC — Gig Harbor, Washington (24.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Northwest Medical Specialties, PLLC ( Site 0093) — Tacoma, Washington (25.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
MultiCare Institute for Research and Innovation — Tacoma, Washington (25.8 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought
Northwest Medical Specialties Tacoma /ID# 276281 — Tacoma, Washington (25.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06158841)

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma (MM) Phase 1 Interventional 258 participants sought
American Oncology Network Vista Oncology Division / Physician partner associate — Olympia, Washington (0.4 mi) · Sponsor: Shanghai Henlius Biotech
See eligibility & contact on ClinicalTrials.gov (NCT07477587)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Multicare Health System — Tacoma, Washington (25.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 714 participants sought
American Oncology Network Vista Oncology Division-West office — Olympia, Washington (0.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06758401)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Olympia, Washington (0.4 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Central Line Associated Blood Stream Infections (CLABSI) N/A Interventional 17,800 participants sought
Providence St. Peter Hospital — Olympia, Washington (0.4 mi) · Sponsor: Swedish Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT07108660)

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

Non-small Cell Lung Cancer, Melanoma Phase 1 Interventional 174 participants sought
American Oncology Network Vista Oncology Division — Olympia, Washington (0.4 mi) · Sponsor: Shanghai Henlius Biotech
See eligibility & contact on ClinicalTrials.gov (NCT07160335)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Breast Cancer, Breast Cancer Metastatic Phase 1, Phase 2 Interventional 150 participants sought
Northwest Medical Specialties, PLLC — Tacoma, Washington (25.8 mi) · Sponsor: Incyclix Bio
See eligibility & contact on ClinicalTrials.gov (NCT05735080)
Actively enrolling

Studies you may be able to join near Olympia

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Olympia

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Vantage Clinical Research Group

3703 Ensign Rd NE #10A, Olympia, WA 98506
(360) 459-5515

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Providence Regional Cancer System - Lacey

★ 4.4 (23 reviews)
4525 3rd Ave SE #200, Lacey, WA 98503
(360) 754-3934
"Would be a 5, but all the healthy workers taking ALL the parking spots surrounding the handicap spots. There are more than 10 handicapped patients th…"
— Fraser Mack, 3★

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Clinical trials in Olympia: what's recruiting

The Olympia area currently has 234 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Olympia, the most active research areas are:

  • Cancer & Oncology17 studies
  • Heart & Vascular3 studies
  • Immune & Skin2 studies
  • Liver & Kidney2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Olympia, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Olympia

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Olympia participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Olympia pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Olympia, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Olympia?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Olympia?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Olympia.

Paid clinical trials near Olympia

Other metros within reach

Tacoma, WA1,464 Bremerton, WA1,481 Seattle, WA1,510 Bellevue, WA1,520 Marysville, WA200 Vancouver, WA1,021 Portland, OR1,021 Salem, OR116

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Olympia Bladder Issues Due To Spinal Cord Injury in Olympia All conditions

More of WA

Bellevue1,520 Seattle1,510 Bremerton1,481 Tacoma1,464 Vancouver1,021 Spokane291 Marysville200 Kennewick55

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts